Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anup K. Sirbaiya"'
Publikováno v:
Pharmaceutical Nanotechnology. 7:246-256
Background: Nanoparticle technologies used for human administration must be designed to interact with a living host environment. The idea about bioinspired smart drug delivery carriers includes the development of biocompatible nanomaterials which can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09b243f91d44da3f0dff127ac8914c60
https://doi.org/10.2174/2211738507666190425122822
https://doi.org/10.2174/2211738507666190425122822
Publikováno v:
Probiotic Research in Therapeutics ISBN: 9789811582134
Probiotics are the substances used for improving health status by improving the fitness of the intestine and overall host health. Research investigations confirm that correlation exists between intestinal microbiota and carcinogenesis. It has been fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4548be3bc28e7cde76e159bb90ae2233
https://doi.org/10.1007/978-981-15-8214-1_4
https://doi.org/10.1007/978-981-15-8214-1_4
Publikováno v:
Nanoengineered Biomaterials for Advanced Drug Delivery ISBN: 9780081029855
The last decade has witnessed substantial efforts to deliver therapeutic ingredients of diverse nature including small and macromolecules, genes, and biopharmaceutical agents using advanced and novel drug delivery platforms. The advances in nanotechn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd6f756c9d4540ac19ee5ce2ca2c0d32
https://doi.org/10.1016/b978-0-08-102985-5.00008-5
https://doi.org/10.1016/b978-0-08-102985-5.00008-5
Publikováno v:
Pharmaceutical drug delivery systems and vehicles ISBN: 9781315364353
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3531c951664d51c08a330cfda41bfa4
https://doi.org/10.1201/9781315364353-12
https://doi.org/10.1201/9781315364353-12
Publikováno v:
Journal of Drug Delivery and Therapeutics. 7
Amikacinis a semisynthetic derivative of Kanamycin; it was approved for clinical use in the U.S. in 1976. Amikacin is broad-spectrum and potent aminoglycoside with limited clinical use owing high dose requirement.Many gram-negative bacteria, includin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c06e9fc6ff9faa3332ddce006192bf5c
https://doi.org/10.22270/jddt.v7i3.1449
https://doi.org/10.22270/jddt.v7i3.1449